Proje dan\u0131\u015fmanl\u0131\u011f\u0131n\u0131 Ege \u00dcniversitesi(E\u00dc) Hem\u015firelik Fak\u00fcltesi Kad\u0131n Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Hem\u015fireli\u011fi Anabilim Dal\u0131ndan Prof. Dr. Oya Kavlak\u2019\u0131n, proje y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcn\u00fc Ar\u015f. G\u00f6r. Ruken Ya\u011f\u0131z Alt\u0131nta\u015f\u2019\u0131n \u00fcstlendi\u011fi ve Uzman Dr. Berk G\u00f6ktepe\u2019nin ara\u015ft\u0131rmac\u0131 olarak yer ald\u0131\u011f\u0131 \u201cKanser Tan\u0131s\u0131 Alan Kad\u0131nlarda Watson\u2019\u0131n \u0130nsan Bak\u0131m Kuram\u0131na Temellendirilmi\u015f Dan\u0131\u015fmanl\u0131\u011f\u0131n Fertilite Endi\u015fesi \u00dczerine Etkisi: Randomize Kontroll\u00fc \u00c7al\u0131\u015fma\u201d projesi T\u00dcB\u0130TAK 1002 – A H\u0131zl\u0131 Destek Mod\u00fcl\u00fc taraf\u0131ndan desteklenmeye uygun bulundu.Proje kapsam\u0131nda, kanser tan\u0131s\u0131 alan kad\u0131nlara gereken bilgi ve desteklerin multidisipliner ekip taraf\u0131ndan sunulmas\u0131, \u00fcreme \u00e7a\u011f\u0131ndaki kad\u0131nlar i\u00e7in \u00f6nemli olan fertilite konusunda do\u011fru bilgilere ula\u015fmalar\u0131 ve bu bilgilerin kuramsal teorik bir \u00e7er\u00e7eveye dayal\u0131 olmas\u0131 ve fertilite endi\u015felerini azaltacak y\u00f6nde kad\u0131nlara destek sa\u011flanmas\u0131 ama\u00e7lan\u0131yor.<\/p>\n
\u201cKanser tan\u0131s\u0131 alan kad\u0131nlarda fertilite endi\u015fesi incelenecek\u201d<\/strong><\/p>\n Proje ekibini tebrik eden Ege \u00dcniversitesi Rekt\u00f6r\u00fc Prof. Dr. Necdet Budak, \u201cTam akredite bir ara\u015ft\u0131rma \u00fcniversitesi olarak bilgi birikimimizi toplumun her kesimiyle bulu\u015fturmaya devam ediyoruz. Bilimsel potansiyelini ulusal ve uluslararas\u0131 kurum ve kurulu\u015flarla payla\u015fan \u00fcniversitemiz, her ge\u00e7en g\u00fcn ba\u015far\u0131 ivmesini daha ileri noktaya ta\u015f\u0131yor. \u00dcniversitemiz b\u00fcnyesinde y\u00fcr\u00fct\u00fclen projelerin T\u00dcB\u0130TAK nezdinde desteklenmesi de bizleri ziyadesiyle gururland\u0131r\u0131yor. Proje kapsam\u0131nda, kanser tan\u0131s\u0131 alan kad\u0131nlarda Watson\u2019\u0131n \u0130nsan Bak\u0131m Kuram\u0131na temellendirilmi\u015f, ara\u015ft\u0131rmac\u0131 taraf\u0131ndan haz\u0131rlanan g\u00f6r\u00fc\u015fme rehberine dayal\u0131 dan\u0131\u015fmanl\u0131k vererek, verilen dan\u0131\u015fmanl\u0131\u011f\u0131n fertilite endi\u015fesi \u00fczerine etkisi incelenecek. Proje ekibimizi tebrik ediyor \u00e7al\u0131\u015fmalar\u0131nda ba\u015far\u0131lar diliyorum\u201d diye konu\u015ftu.<\/p>\n Her y\u0131l, 15-39 ya\u015f aral\u0131\u011f\u0131ndaki bireylere 70 binden fazlas\u0131na kanser te\u015fhisi konulmakta<\/strong><\/p>\n Her be\u015f ki\u015fiden birinin ya\u015fam\u0131 boyunca kansere yakalanma riski ta\u015f\u0131d\u0131\u011f\u0131n\u0131 ifade eden Prof. Dr. Kavlak, \u201cKanser, \u00fclkemizde ve d\u00fcnya genelinde \u00f6l\u00fcm nedenleri aras\u0131nda ikinci s\u0131rada yer almaktad\u0131r. \u00d6zellikle d\u00fcnya genelinde her 11 kad\u0131ndan biri kanser nedeniyle ya\u015fam\u0131n\u0131 yitirmektedir. Kanser te\u015fhisi konulduktan sonra, ilk be\u015f y\u0131l i\u00e7inde hayatta kalan kanser hastalar\u0131n\u0131n say\u0131s\u0131 yakla\u015f\u0131k 50,6 milyon olarak tahmin edilmektedir ve bu hastalar\u0131n yakla\u015f\u0131k yar\u0131s\u0131 kad\u0131nlardan olu\u015fmaktad\u0131r. Bu veriler, kanserin toplumun genel sa\u011fl\u0131\u011f\u0131n\u0131 etkileyen ciddi bir sorun oldu\u011funu g\u00f6stermektedir. \u00d6zellikle 15-39 ya\u015f aral\u0131\u011f\u0131ndaki bireyler aras\u0131nda her y\u0131l 70 binden fazla kanser te\u015fhisi konuldu\u011funu g\u00f6rmekteyiz\u201d dedi.<\/p>\n \u00a0\u201cBir\u00e7ok kad\u0131n anksiyete ve stres ya\u015famakta\u201d<\/strong><\/p>\n Kanser tedavisi g\u00f6ren pek \u00e7ok kad\u0131n\u0131n \u00fcreme kapasitesi hakk\u0131nda belirsizlik ya\u015fad\u0131\u011f\u0131n\u0131 s\u00f6yleyen Prof. Dr. Kavlak, \u201cKanserin tedavisindeki ilerlemeler, hayatta kalma oranlar\u0131n\u0131 olumlu bir \u015fekilde etkilese de, tedavi y\u00f6ntemleri fertilitenin ve endokrin sisteminin sa\u011fl\u0131\u011f\u0131n\u0131 olumsuz etkileyebilir. Bu nedenle, bir\u00e7ok kad\u0131n kanser te\u015fhisi ald\u0131ktan sonra gelecekteki \u00fcreme kapasiteleri hakk\u0131nda belirsizlik ya\u015far, bu da kad\u0131nlar aras\u0131nda endi\u015fe, anksiyete ve stresin kayna\u011f\u0131d\u0131r. Bunun \u00f6nemli nedenlerinden biri \u00fcreme sa\u011fl\u0131\u011f\u0131 dan\u0131\u015fmanl\u0131\u011f\u0131n\u0131n eksik ve yetersiz olarak yap\u0131lmas\u0131d\u0131r. Bir\u00e7ok kad\u0131n fertilite ve ebeveynlikleri hakk\u0131nda bilgi yetersizli\u011finden kaynakl\u0131 anksiyete ve stres gibi durumlar\u0131 daha s\u0131k ya\u015famaktad\u0131r. Bu do\u011frultuda hem\u015fireler, sa\u011fl\u0131\u011f\u0131n geli\u015ftirilmesi ve korunmas\u0131, tan\u0131, prehabilitasyon, tedavi ve rehabilitasyon a\u015famalar\u0131nda \u00e7ok y\u00f6nl\u00fc bak\u0131m sa\u011flayan sa\u011fl\u0131k profesyonelleridir. Bu sorumluluklar hem\u015fireli\u011fin do\u011fas\u0131nda var olmakla beraber, onkoloji alan\u0131ndaki hem\u015firenin dan\u0131\u015fmanl\u0131k konular\u0131n\u0131, hedeflerini, kapsam\u0131n\u0131 iyi bilmesi ve gerekli konularda kendini geli\u015ftirmesi gerekmektedir\u201d dedi.<\/p>\n \n \n \n \n \n \n \n \n","protected":false},"excerpt":{"rendered":" Proje dan\u0131\u015fmanl\u0131\u011f\u0131n\u0131 Ege \u00dcniversitesi(E\u00dc) Hem\u015firelik Fak\u00fcltesi Kad\u0131n Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Hem\u015fireli\u011fi Anabilim Dal\u0131ndan Prof. Dr….<\/p>\n","protected":false},"author":2,"featured_media":20012,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,99,1,11,68],"tags":[],"class_list":["post-20011","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bilim","category-egitim","category-gncl","category-haber","category-saglik"],"featured_image_urls":{"full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti.jpg",1500,1000,false],"thumbnail":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti-150x150.jpg",150,150,true],"medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti-768x512.jpg",640,427,true],"large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti-1024x683.jpg",640,427,true],"1536x1536":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti.jpg",1500,1000,false],"2048x2048":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti.jpg",1500,1000,false],"newsphere-slider-full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti-1280x720.jpg",1280,720,true],"newsphere-featured":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti-1024x683.jpg",1024,683,true],"newsphere-medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/03\/Prof-Dr-Necdet-Budak_Prof.Dr-Oya-Kavlak-Ars.Gor_.-Ruken-Yagiz-Altintas-Proje-Ziyareti-720x380.jpg",720,380,true]},"author_info":{"display_name":"Editor","author_link":"https:\/\/www.euegeajans.com\/index.php\/author\/editor\/"},"category_info":"Bilim<\/a> E\u011fitim<\/a> G\u00fcncel<\/a> Haber<\/a> Sa\u011fl\u0131k<\/a>","tag_info":"Sa\u011fl\u0131k","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/20011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/comments?post=20011"}],"version-history":[{"count":1,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/20011\/revisions"}],"predecessor-version":[{"id":20013,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/20011\/revisions\/20013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media\/20012"}],"wp:attachment":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media?parent=20011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/categories?post=20011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/tags?post=20011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}